Skip to main content
Top
Published in: Rheumatology International 11/2023

Open Access 23-08-2023 | Uveitis | Observational Research

Higher frequency but similar recurrence rate of uveitis episodes in axial spondylarthritis compared to psoriatic arthritis. A multicentre retrospective study

Authors: Nikolaos Kougkas, Konstantina Magiouf, Chrysoula G. Gialouri, Gerasimos Evangelatos, Maria Pappa, Aikaterini Dimouli, Alexios Iliopoulos, Anastasios Karmanakos, Theodoros Dimitroulas, Maria G. Tektonidou, Petros P. Sfikakis, George E. Fragoulis

Published in: Rheumatology International | Issue 11/2023

Login to get access

Abstract

Background/Objective

Data on risk factors predicting uveitis development in spondyloarthritis (SpA) is scarce. Our aim was to examine associations between demographic, clinical and/or laboratory characteristics of SpA with the occurrence and the course of uveitis, including ocular damage and recurrence rate.

Methods

Characteristics (at disease diagnosis and ever-present) from axSpA and Psoriatic arthritis (PsA) patients followed in 3 tertiary rheumatology-clinics were retrospectively recorded. Comparisons were made between patients with and without uveitis, as well as between those with uveitis-rate [episodes/year] above the median uveitis-rate in the whole cohort (“recurrent”-uveitis) and the remaining uveitis patients (“non-recurrent uveitis”). In multivariable models, age, gender and variables significantly different in univariate analyses were included.

Results

264 axSpA and 369 PsA patients were enrolled. In axSpA, uveitis occurred in 11.7% and was associated with HLA-B27 (OR = 4.15, 95%CI 1.16–14.80, p = 0.028) and ever-present peripheral arthritis (OR = 3.05 (1.10–8.41, p = 0.031). In contrast, uveitis in PsA occurred only in 2.7% of patients and was associated with SpA family-history (OR = 6.35 (1.29–31.27), p = 0.023) axial disease at diagnosis (OR = 5.61 [1.01–28.69], p = 0.038) and disease duration (OR = 1.12 [1.04–1.21], p = 0.004). Median uveitis recurrence rate was comparable between axSpA and PsA (0.205 and 0.285 episodes/year, respectively). No associations were found between recurrent uveitis and demographic/clinical/laboratory characteristics. Ocular damage (e.g. synechiae) was seen in 16.1% of axSpA and 30% of PsA patients, all of them with recurrent uveitis.

Conclusion

Uveitis occurred more commonly in axSpA than in PsA patients, while uveitis recurrence rate was similar. Permanent ocular damage may occur more often in PsA than axSpA.
Appendix
Available only for authorised users
Literature
13.
go back to reference Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. vol. 6. 2013. Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. vol. 6. 2013.
19.
20.
go back to reference Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA et al (2019) 2019 Update of the American College of Rheumatology/Spondylitis Association of America/spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis and Rheumatology 71:1599–1613. https://doi.org/10.1002/art.41042CrossRefPubMed Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA et al (2019) 2019 Update of the American College of Rheumatology/Spondylitis Association of America/spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis and Rheumatology 71:1599–1613. https://​doi.​org/​10.​1002/​art.​41042CrossRefPubMed
27.
go back to reference Poddubnyy D, Baraliakos X, Van den Bosch F, Braun J, Coates LC, Chandran V et al (2021) Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Ther Adv Musculoskelet Dis. https://doi.org/10.1177/1759720X211057975CrossRefPubMedPubMedCentral Poddubnyy D, Baraliakos X, Van den Bosch F, Braun J, Coates LC, Chandran V et al (2021) Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Ther Adv Musculoskelet Dis. https://​doi.​org/​10.​1177/​1759720X21105797​5CrossRefPubMedPubMedCentral
Metadata
Title
Higher frequency but similar recurrence rate of uveitis episodes in axial spondylarthritis compared to psoriatic arthritis. A multicentre retrospective study
Authors
Nikolaos Kougkas
Konstantina Magiouf
Chrysoula G. Gialouri
Gerasimos Evangelatos
Maria Pappa
Aikaterini Dimouli
Alexios Iliopoulos
Anastasios Karmanakos
Theodoros Dimitroulas
Maria G. Tektonidou
Petros P. Sfikakis
George E. Fragoulis
Publication date
23-08-2023
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 11/2023
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-023-05424-0

Other articles of this Issue 11/2023

Rheumatology International 11/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine